AMORPHOUS FLUTICASONE 2-FUROATE, PHARMACEUTICAL COMPOSITIONS THEREOF AND ITS CONVERSION TO THE CRYSTALLINE UNSOLVATED FORM

摘要

According to one aspect of the invention, there is provided a compound of formula (I) in the form of a substantially amorphous solid.